MRMohammad Usman Rana

Mohammad Usman Rana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad Usman Rana has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Arild André Østhus

    Department of Otorhinolaryngology & Head and Neck Surgery, Oslo University Hospital, Rikshospitalet, Norway

    1 shared publication
  • Ketil Heimdal

    Department of Medical Genetics, Oslo University Hospital, Rikshospitalet, Norway

    1 shared publication
  • Mona-Elisabeth Revheim

    The Intervention Centre, Oslo University Hospital, 0372 Oslo, Norway

    1 shared publication
  • Peter Jebsen

    Department of Pathology, Oslo University Hospital, Rikshospitalet, Norway

    1 shared publication
  • Terje Andreas Osnes

    Department of Otorhinolaryngology & Head and Neck Surgery, Oslo University Hospital, Rikshospitalet, Norway

    1 shared publication

Latest Publications

  • Open Access

    Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment

    by Mohammad Usman Rana, Arild André Østhus, Ketil Heimdal, Peter Jebsen, Mona-Elisabeth R. Revheim, Terje Andreas Osnes

    Background Head and neck paragangliomas (HNPG) are rare and predominantly benign tumours, originating from the neuroendocrine paraganglionic system. A considerable proportion of HNPGs are hereditary, depending on the population. Aims/objectives The purpose of this study was to estimate the rate of hereditary HNPGs in a Scandinavian (Norwegian) population, report long-term experience with HNPGs and offer all patients diagnosed an updated follow-up, with emphasis on identifying hereditary HNPGs through genetic screening and multifocality by 18 F-2-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT). Material and methods Our study was a partly retrospective and partly prospective cohort study. It included patients with HNPG diagnosed at Oslo University Hospital (OUH), Rikshospitalet between 1990 and 2017. The patients underwent genetic testing, F-18-FDG PET/CT and measurement of catecholamines and meta-nephrines in the plasma. All resection specimens and biopsies were subjected to histopathological review. The genetic testing protocol consisted of testing for mutations in the following genes; SDHD, SDHB, SDHC, VHL and RET. Results Sixty-three patients were included in the study with a median age of 49 years (range 12 - 80). Cranial nerve dysfunction was present upon diagnosis in 13%, and 14% had multifocal paraganglioma (PG) disease. Fifty-six patients (89% of all the patients) underwent genetic testing, and 29% of these had a PG related mutation. Seven of the eight patients (88%) with multifocal PGs who underwent genetic testing had a mutation. In two of the patients, the F-18-FDG PET/CT revealed unknown and subclinical multifocality. Conclusions and significance This is the first study with systematic genetic workup and PET/CT imaging in Scandinavia of HNPG patients. The mutation rate was within the lower range reported in the literature with respect to HNPGs. Combining genetic testing and PET/CT imaging in the diagnostic workup of HNPGs is valuable.